Rion Co., Ltd. (JP:6823)
:6823
Want to see JP:6823 full AI Analyst Report?
6823 Stock Chart & Stats
¥2691.00
-¥68.00(-2.64%)
At close: 4:00 PM EST
¥2691.00
-¥68.00(-2.64%)
Day’s Range― - ―
52-Week Range¥2,294.00 - ¥3,445.00
Previous CloseN/A
Volume32.10K
Average Volume (3M)26.46K
Market Cap
¥41.74B
Enterprise Value¥34.14B
Total Cash (Recent Filing)¥6.16B
Total Debt (Recent Filing)¥1.73B
Price to Earnings (P/E)10.2
Beta1.11
Next Earnings
Aug 05, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.93%
Share Statistics
EPS (TTM)88.99
Shares Outstanding12,347,700
10 Day Avg. Volume21,140
30 Day Avg. Volume26,463
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)283.9
Revenue Forecast (FY)¥30.00B
Bulls Say, Bears Say
Bulls Say
Conservative Balance Sheet / Negligible DebtA near-zero debt position and rising equity (¥23.7B → ¥34.8B) provide financial resilience and flexibility. This durable conservatism lowers refinancing and solvency risk, supporting steady operations, dividend capacity, and optionality for capex or M&A over the next 2–6 months.
Steady Multi-year Revenue And Improving ProfitsConsistent top-line expansion with materially higher net income demonstrates underlying demand for measurement and medical devices. Sustained revenue and profit improvement indicate product-market fit and diversification across industrial and healthcare customers, supporting persistent earnings power.
Improving Cash Generation And Free Cash FlowStronger operating and free cash flow enhance the company's ability to fund maintenance capex, R&D, and after-sales services without relying on debt. Reliable cash generation supports durable shareholder returns and reinvestment priorities over the medium term.
Bears Say
Volatile Free Cash Flow And Working Capital SwingsMaterial FCF swings suggest sensitivity to working capital and investment timing, which can constrain predictable funding for R&D, inventory, or distributor support. Continued volatility could pressure short-term execution and capital allocation over the coming quarters.
Gross Profit Softness / Margin Visibility RiskA decline in gross profit dollars amid revenue growth signals rising input or operating costs and weak margin leverage. Limited margin disclosure for 2026 makes it harder to confirm sustained operating leverage, introducing risk to profit durability if cost pressures persist.
Modest Returns On Equity / Capital EfficiencyROE under 10% indicates moderate capital efficiency relative to higher-return peers. With a very conservative balance sheet, growth funded internally may produce only modest incremental returns unless management boosts asset turnover or targets higher-return investments, limiting upside.
Rion Co., Ltd. News
6823 FAQ
What was Rion Co., Ltd.’s price range in the past 12 months?
Rion Co., Ltd. lowest stock price was ¥2294.00 and its highest was ¥3445.00 in the past 12 months.
What is Rion Co., Ltd.’s market cap?
Rion Co., Ltd.’s market cap is ¥41.74B.
When is Rion Co., Ltd.’s upcoming earnings report date?
Rion Co., Ltd.’s upcoming earnings report date is Aug 05, 2026 which is in 96 days.
How were Rion Co., Ltd.’s earnings last quarter?
Rion Co., Ltd. released its earnings results on Apr 28, 2026. The company reported ¥88.99 earnings per share for the quarter, beating the consensus estimate of N/A by ¥88.99.
Is Rion Co., Ltd. overvalued?
According to Wall Street analysts Rion Co., Ltd.’s price is currently Overvalued.
Does Rion Co., Ltd. pay dividends?
Rion Co., Ltd. pays a Semiannually dividend of ¥35 which represents an annual dividend yield of 2.93%. See more information on Rion Co., Ltd. dividends here
What is Rion Co., Ltd.’s EPS estimate?
Rion Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Rion Co., Ltd. have?
Rion Co., Ltd. has 12,347,700 shares outstanding.
What happened to Rion Co., Ltd.’s price movement after its last earnings report?
Rion Co., Ltd. reported an EPS of ¥88.99 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.772%.
Which hedge fund is a major shareholder of Rion Co., Ltd.?
Currently, no hedge funds are holding shares in JP:6823
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Rion Co., Ltd.
Rion Co., Ltd. manufactures, sells, and maintains hearing instruments, medical equipment, sound and vibration measuring instruments, particle counters, and related parts and equipment in Japan. The company's audiological equipment includes hearing instruments, such as analog and digital BTE, trimmer digital BTE, in-the-ear ready and custom made, and analog body aid instruments, as well as waterproof hearing instruments; and medical equipment comprising audiometers and OAE screeners. Its sound and vibration measuring instruments include sound level meters, vibration meters, seismometers, frequency analyzers, microphones and accelerometers, recorders, and other products. The company's particle counters comprise air and liquid- borne particle counters, and viable particle counters. Its products are primarily used in the applications of environment-related administration, electronics, semiconductors, pharmaceutical, and food manufacturing industries. The company was formerly known as Kobayashi-Riken Seisakusho Ltd. and changed its name to Rion Co., Ltd. in 1960. Rion Co., Ltd. was incorporated in 1944 and is headquartered in Kokubunji, Japan.
Technical Analysis
PHC Holdings Corp.
―
Eiken Chemical Co., Ltd.
―
Techno Medica Co., Ltd.
―
Nihon Kohden Corporation
―
Japan Medical Dynamic Marketing, Inc.
―
Options Prices
Currently, No data available
---